Tag Archives: cardiac magnetic resonance imaging
February 2023 Br J Cardiol 2023;30:35–8 doi:10.5837/bjc.2023.007
Cardiac sarcoidosis: the role of cardiac MRI and 18F-FDG-PET/CT in the diagnosis and treatment follow-up
Muntasir Abo Al Hayja, Sobhan Vinjamuri
Introduction Cardiac sarcoidosis (CS) is associated with increased morbidity and mortality.1 Thus, early diagnosis is crucial to introducing immunosuppressive therapy that could prevent an adverse outcome.2 This focused review will discuss the pathology of CS, when to suspect and evaluate CS, and highlight the roles of advanced imaging modalities, i.e. cardiac magnetic resonance imaging (MRI) and positron emission tomography (PET) with 18F-Fluorodeoxyglucose/computed tomography (CT) scan (18F-FDG-PET/CT), and their diagnostic and prognostic values in CS in the current content of guidelines for the diagnostic workflow of CS.3 Epidemiology and
September 2014 Br J Cardiol 2014;21:120 doi:10.5837/bjc.2014.030
Endomyocardial fibrosis in hypereosinophilic syndrome
Theodore M Murphy, Deirdre F Waterhouse, Stephanie James, Niamh Murphy, Rory O’Hanlon
(more…)
November 2009 Br J Cardiol 2009;16:303–4
Contrast enhanced cardiac magnetic resonance in the decision making for revascularisation
Khaled Alfakih, Kate Pointon, Thomas Mathew
Figure 1. A short-axis slice of the mid left ventricle illustrating contrast enhancement in the anterior segment (25% transmurality – viable), anterolateral segment (50–75% transmurality – non-viable), inferolateral segment (50% transmurality – potentially viable) Case 1 Mr K P is a 45-year-old man who presented to our hospital with symptoms of exertional breathlessness. His LV function was found to be severely impaired on echocardiography and it was initially thought that he had ‘dilated cardiomyopathy’. As he had a strong family history of coronary artery disease and was an ex-smoker, he underwent X-ray coronary angiography. He
For healthcare professionals only
